icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 13 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.

A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.

icon 2020-07-04
عنوان الدراسة
A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.
داعم الدراسة
Novartis
دواء الدراسة
Vildagliptin /Gliclazide / Metformin
رقم بروتوكول الدراسة
CLAF237A2411
حالة الدراسة
Completed
موقع الدراسة
King Fahad University Hospital (Al-Khobar)_ King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
4